These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4096701)

  • 41. Detection of aneuploidy in human and rodent sperm using FISH and applications of sperm assays of genetic damage in heritable risk evaluation.
    Wyrobek AJ; Adler ID
    Mutat Res; 1996 Jun; 352(1-2):173-9. PubMed ID: 8676907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Procedures for the detection of chemically induced aneuploidy: recommendations of a UK Environmental Mutagen Society working group.
    Parry EM; Henderson L; Mackay JM
    Mutagenesis; 1995 Jan; 10(1):1-14. PubMed ID: 7739395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of mitotic aneuploidy using Chinese hamster primary embryonic cells. Test results of 10 chemicals.
    Natarajan AT; Duivenvoorden WC; Meijers M; Zwanenburg TS
    Mutat Res; 1993 May; 287(1):47-56. PubMed ID: 7683384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of short term in vitro and submammalian tests as alternatives to large scale animal bioassays.
    Brusick DJ
    Ann N Y Acad Sci; 1983; 406():68-73. PubMed ID: 6576674
    [No Abstract]   [Full Text] [Related]  

  • 45. Detection and characterization of mechanisms of action of aneugenic chemicals.
    Parry EM; Parry JM; Corso C; Doherty A; Haddad F; Hermine TF; Johnson G; Kayani M; Quick E; Warr T; Williamson J
    Mutagenesis; 2002 Nov; 17(6):509-21. PubMed ID: 12435848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of the Miniscreen assay to screen novel compounds for bacterial mutagenicity in the pharmaceutical industry.
    Burke DA; Wedd DJ; Burlinson B
    Mutagenesis; 1996 Mar; 11(2):201-5. PubMed ID: 8671739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tradescantia cytogenetic tests (root-tip mitosis, pollen mitosis, pollen mother-cell meiosis). A report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Ma TH
    Mutat Res; 1982 Nov; 99(3):293-302. PubMed ID: 7177155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mammalian in vivo assays for aneuploidy in female germ cells.
    Mailhes JB; Preston RJ; Lavappa KS
    Mutat Res; 1986; 167(1-2):139-48. PubMed ID: 3941671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overlap between mutagens and teratogens.
    Ferguson LR; Ford JH
    Mutat Res; 1997 Dec; 396(1-2):1-8. PubMed ID: 9434857
    [No Abstract]   [Full Text] [Related]  

  • 50. Salmonella electrode for screening mutagens.
    Karube I; Nakahara T; Matsunaga T; Suzuki S
    Anal Chem; 1982 Sep; 54(11):1725-7. PubMed ID: 6756209
    [No Abstract]   [Full Text] [Related]  

  • 51. Testing for the chemical induction of aneuploidy in the male mouse.
    Brook JD; Chandley AC
    Mutat Res; 1986 Apr; 164(2):117-25. PubMed ID: 3960041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aneuploidy induced by cyclophosphamide in developing rat testes.
    Saxena AK; Singh G
    In Vitro Cell Dev Biol Anim; 1998 Jan; 34(1):11-3. PubMed ID: 9542625
    [No Abstract]   [Full Text] [Related]  

  • 53. Mechanisms of spontaneous and chemically-induced aneuploidy in mammalian oogenesis: basis of sex-specific differences in response to aneugens and the necessity for further tests.
    Eichenlaub-Ritter U; Baart E; Yin H; Betzendahl I
    Mutat Res; 1996 Dec; 372(2):279-94. PubMed ID: 9015146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aspergillus nidulans: systems and results of tests for induction of mitotic segregation and mutation. II. Haploid assay systems and overall response of all systems. A report of the U.S. EPA Gene-Tox Program.
    Scott BR; Dorn GL; Käfer E; Stafford R
    Mutat Res; 1982 Jan; 98(1):49-94. PubMed ID: 7038473
    [No Abstract]   [Full Text] [Related]  

  • 55. Induction of gene mutations in germ cells of the mouse.
    Ehling UH
    Arch Toxicol; 1980 Nov; 46(1-2):123-38. PubMed ID: 7235989
    [No Abstract]   [Full Text] [Related]  

  • 56. Mutagenicity, carcinogenicity and teratogenicity of zinc.
    Léonard A; Gerber GB; Léonard F
    Mutat Res; 1986 Nov; 168(3):343-53. PubMed ID: 3540646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme.
    Eastmond DA; Hartwig A; Anderson D; Anwar WA; Cimino MC; Dobrev I; Douglas GR; Nohmi T; Phillips DH; Vickers C
    Mutagenesis; 2009 Jul; 24(4):341-9. PubMed ID: 19535363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation of tests for carcinogenicity.
    Purchase IF
    IARC Sci Publ; 1980; (27):343-9. PubMed ID: 7002781
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.
    Hales BF
    Cancer Res; 1982 Aug; 42(8):3016-21. PubMed ID: 7046914
    [No Abstract]   [Full Text] [Related]  

  • 60. [The necessity of determining the mutagenicity of new drugs].
    Bogajewski J; Schöneich J
    Pol Tyg Lek; 1982 Mar; 37(2):63-7. PubMed ID: 6750579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.